VIVIDRIN

This brand name is authorized in Cyprus, Germany, Ireland, Poland, Singapore, United Kingdom

Active ingredients

The drug VIVIDRIN contains one active pharmaceutical ingredient (API):

1 Cromoglicate sodium UNII Q2WXR1I0PK - CROMOLYN SODIUM

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils. Read about Cromoglicic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Vividrin Eye Drops 2% sodium cromoglicate	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AC01	Cromoglicic acid	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC01
S01GX01	Cromoglicic acid	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 03561555, 16507327
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 214137
Country: IE	Health Products Regulatory Authority	Identifier(s): 53201, 53245
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100204917
Country: SG	Health Sciences Authority	Identifier(s): 04854P